Ticker
TCRXCompany Name
TSCAN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Revenues | Stock Based Compensation | Stock Based Compensation Margin |
---|---|---|---|
6/30/2025 | $ 6.96M | $ 11.92M | 171.3% |
3/31/2025 | $ 4.42M | $ 10.98M | 248.34% |
12/31/2024 | $ 2.82M | $ 9.55M | 339.1% |
9/30/2024 | $ 9.36M | $ 8.34M | 89.03% |
6/30/2024 | $ 12.2M | $ 7.15M | 58.63% |
3/31/2024 | $ 14.81M | $ 6.04M | 40.81% |
12/31/2023 | $ 21.05M | $ 5.21M | 24.74% |
9/30/2023 | $ 16.93M | $ 5M | 29.56% |
6/30/2023 | $ 16.41M | $ 4.91M | 29.92% |
3/31/2023 | $ 17.32M | $ 4.71M | 27.22% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
SB Comp. / Revenues
(=) SB Comp %
SB Comp % for TSCAN THERAPEUTICS INC is calculated as follows: SB Comp. [ $ 515K ] / Revenues [ $ 1.08M ]
(=) SB Comp % [ 47.47% ]
Minimum
Dec 31, 2023
Maximum
Dec 31, 2024
Average
Median
filtered constituents | 2.98K |
---|---|
min | -3.97% |
max | 8.43% |
average | 1.72% |
median | 1.04% |
std | 1.9% |